1. Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer. 2009; 115:3919–3923.
Article
2. Halkes CJ, Dijstelbloem HM, Eelkman Rooda SJ, Kramer MH. Extreme leucocytosis: not always leukaemia. Neth J Med. 2007; 65:248–251.
3. Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013; 27:1870–1873.
Article
4. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013; 368:1781–1790.
Article
5. Aliper AM, Frieden-Korovkina VP, Buzdin A, Roumiantsev SA, Zhavoronkov A. A role for G-CSF and GM-CSF in nonmyeloid cancers. Cancer Med. 2014; 3:737–746.
Article
6. Blombery P, Kothari J, Yong K, Allen C, Gale RE, Khwaja A. Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutations. Leuk Lymphoma. 2014; 55:1661–1662.
Article
7. Bain BJ, Ahmad S. Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions. Br J Haematol. 2015; 171:400–410.
Article
8. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer. 2001; 92:2399–2405.
Article
9. Kitamura H, Kodama F, Odagiri S, Nagahara N, Inoue T, Kanisawa M. Granulocytosis associated with malignant neoplasms: a clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. Hum Pathol. 1989; 20:878–885.
Article
10. Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood. 1989; 73:80–83.
Article
11. Nakayama S, Yokote T, Iwaki K, Hirata Y, Akioka T, Miyoshi T, et al. Co-expression of multiple cytokines and their receptors in primary clear cell sarcoma of the pubic bone with features of a small round cell tumor. Int J Immunopathol Pharmacol. 2012; 25:799–804.
Article
12. Dorn C, Bugl S, Malenke E, Muller MR, Weisel KC, Vogel U, et al. Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report. BMC Res Notes. 2014; 7:313.
Article
13. Kumar AK, Satyan MT, Holzbeierlein J, Mirza M, Van Veldhuizen P. Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature. J Med Case Rep. 2014; 8:147.
14. Qing L, Xiang T, Guofu Z, Weiwei F. Leukemoid reaction in cervical cancer: a case report and review of the literature. BMC Cancer. 2014; 14:670.
Article
15. Nimieri HS, Makoni SN, Madziwa FH, Nemiary DS. Leukemoid reaction response to chemotherapy and radiotherapy in a patient with cervical carcinoma. Ann Hematol. 2003; 82:316–317.
Article
16. Elliott MA, Tefferi A. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management. Am J Hematol. 2016; 91:341–349.
Article
17. Nedeljkovic M, He S, Szer J, Juneja S. Chronic neutrophilia associated with myeloma: is it clonal. Leuk Lymphoma. 2014; 55:439–440.
Article